SCHEMBL30585285

SCHEMBL30585285

COc1ccc(C(CN2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)S(N)(=O)=O)cn1

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
LMNA P02545 1/20 0.43
MYD88 Q99836 1/20 0.43
KCNJ1 P48048 1/20 0.42
KCNH2 Q12809 1/20 0.42
KDM4E B2RXH2 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HTT P42858 1/20 0.41
CCR2 P41597 1/20 0.40
ABCC1 P33527 1/20 0.40
NPC1 O15118 1/20 0.40
NR2F2 P24468 1/20 0.40
MAPK1 P28482 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30585268 0.90 MYD88 (0.55) ALDH1A1LMNAMYD88KDM4ESMN1; SMN2
SCHEMBL30585277 0.89 IGF1R (0.47) ALDH1A1LMNAMYD88SMN1; SMN2HTT
SCHEMBL30585270 0.79 ALDH1A1 (0.46) ALDH1A1LMNAKDM4ESMN1; SMN2HTT
SCHEMBL30585281 0.76 KDM4E (0.42) ALDH1A1LMNAKDM4ESMN1; SMN2MAPK1
SCHEMBL29078361 0.74 MYD88 (0.55) ALDH1A1LMNAMYD88KCNJ1KCNH2
SCHEMBL30205261 0.72 MYD88 (0.48) ALDH1A1LMNAMYD88KDM4ESMN1; SMN2
SCHEMBL29078394 0.71 MEN1 (0.60) ALDH1A1LMNAMYD88KDM4ESMN1; SMN2
SCHEMBL29078407 0.71 ALDH1A1 (0.50) ALDH1A1LMNAKCNJ1KDM4ESMN1; SMN2
SCHEMBL30585272 0.70 ALDH1A1 (0.55) ALDH1A1LMNAMYD88KDM4ESMN1; SMN2
SCHEMBL14564424 0.68 ALDH1A1 (0.70) ALDH1A1LMNAKCNJ1KCNH2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116803981-A Piperazine-containing amide or sulfonamide anti-inflammatory compound and preparation method and application thereof 温州医科大学 2023-09-26 CN disclosed